Skeletal Disease Models

Overview

The Pharmatest preclinical contract research organization (CRO) offers full-service efficacy testing of new drug candidates for treatment of osteoporosis and osteoarthritis. Pharmatest osteoporosis models include in vitro bone cell cultures (osteoclasts and osteoblasts) and animal models of primary and secondary osteoporosis.

Capabilities

The bone cell cultures can be conveniently used for identifying compounds with best efficacy for subsequent testing in animal studies. With the osteoporosis animal models Pharmatest offers specially designed study setups for testing anti-catabolic and anabolic compounds in prevention and treatment settings. Projects can range from preliminary studies to regulatory studies performed according to the guidelines of FDA and EMEA. The preclinical CRO has also designed special project types for testing biosimilars and functional foods that have less extensive regulatory requirements.

Resources

Click on skeletal disease models for more information.
Click on Pharmatest to contact the company directly.

Supplier Information
Supplier: Pharmatest Services Ltd
Address: Itäinen Pitkäkatu 4 C, 5th floor, 20520 Turku, Finland
Tel: +358 2 278 4700
Fax: +358 2 278 4710
Website: www.pharmatest.com